Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Microbion Corporation logo — Developing a disruptive new class of therapeutic drugs for t...

Microbion Corporation

Developing a disruptive new class of therapeutic drugs for the treatment of rare, chronic, and serious diseases

Founded 2000 United States Bozeman, United States 16 employees Venture round Biotechnology, Health Care +2

General Information

Company Name Microbion Corporation
Founded Year 2000
Location United States Bozeman, United States
Employees 16
Industries Biotechnology, Health Care, Health and Wellness +1
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Microbion Corporation. To contact Microbion Corporation, visit microbioncorp.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Microbion Corporation compare?

A PDF of Microbion Corporation and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Microbion Corporation soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Microbion Corporation

Microbion Corporation is a clinical-stage pharmaceutical company focusing on developing therapeutic compounds for rare and serious diseases. The company's lead drug candidate, pravibismane, has received substantial support, totaling over $21 million in grants from the Cystic Fibrosis Foundation, NIH, US DoD, and CARB-X. Pravibismane has been granted Orphan Drug, Fast Track, and QIDP designations by the FDA and is currently in clinical development for chronic lung diseases and chronic wounds and orthopedic infections. The drug's potent effectiveness against a broad spectrum of pathogens, including "superbugs" as identified by the US CDC, makes it a promising development in the battle against antibiotic resistance. Additionally, Microbion’s site-specific delivery approach is designed to achieve higher therapeutic concentrations at the site of infection and minimize the risk of antibiotic resistance. The company, founded in 2000 and headquartered in the United States, recently received a Venture - Series Unknown investment at 31 March 2021.

Business keywords: Pharmaceuticals, Therapeutics, Drug Development, Clinical-stage Biotechnology, Microbial Biofilm Prevention, Chronic Lung Diseases, Orthopedic Infections, Rare Disease Treatments, Antibiotic Resistance, Inhaled Drug Delivery, Topical Drug Development, Medical Device Coatings, Biofilm Prevention Technologies, Agricultural Biofilm Prevention, Industrial Biofilm Prevention

No funding data available for Microbion Corporation yet.

Microbion Corporation Alternatives & Competitors

View All Alternatives
Microbion Corporation vs
Akthelia Pharmaceuticals
Akthelia Pharmaceuticals Iceland

Modulating innate immunity to improve cancer therapy outcomes. .

Grant
4 employees
Biotechnology, Pharmaceutical
Microbion Corporation vs
Breath Therapeutics
Breath Therapeutics Italy

Since 1906 our mission is innovating Cure & Care to make patients’ lives better.

Series A
2468 employees
Biotechnology, Health Care
Microbion Corporation vs
PolyPid Ltd.
PolyPid Ltd. Israel

Controlled, extended-release, local delivery of medication at effective release rates over predeterm...

Post-IPO Equity
66 employees
Biopharma, Biotechnology
Also compare with: Microbion Corporation vs Spero Therapeutics Spero Therapeutics View all alternatives

FAQ About Microbion Corporation

Developing a disruptive new class of therapeutic drugs for the treatment of rare, chronic, and serious diseases
Microbion Corporation was founded in 2000.
Microbion Corporation is headquartered in Bozeman, United States.
Microbion Corporation operates in Biotechnology, Health Care, Health and Wellness and Pharmaceutical. Its work centres on Pharmaceuticals, Therapeutics, Drug Development and Clinical-stage Biotechnology.
Microbion Corporation has approximately 16 employees.
Top alternatives and competitors to Microbion Corporation include Akthelia Pharmaceuticals, Breath Therapeutics, PolyPid Ltd. , Arpida, Savara Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Microbion Corporation and Akthelia Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Microbion Corporation, https://bouncewatch.com/company/microbion-corporation, updated 30 July 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout